The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis.
Pituitary tumors are common intracranial neoplasms, yet few germline abnormalities have been implicated in their pathogenesis. Here we show that a single nucleotide germline polymorphism (SNP) substituting an arginine (R) for glycine (G) in the FGFR4 transmembrane domain can alter pituitary cell gro...
Main Authors: | Toru Tateno, Sylvia L Asa, Lei Zheng, Thomas Mayr, Axel Ullrich, Shereen Ezzat |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-12-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC3234213?pdf=render |
Similar Items
-
The role of MMP-1 and FGFR4-R388 gene polymorphisms in pituitary adenoma
by: Eglė Zlatkutė, et al.
Published: (2018-01-01) -
An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism
by: Sylvia L. Asa, et al.
Published: (2021-05-01) -
Deactivation of STAT6 through serine 707 phosphorylation by JNK
by: Shirakawa, Takashi
Published: (2011) -
Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer
by: Tao Peng, et al.
Published: (2021-01-01) -
Phosphorylation of STAT1 Serine 727 Enhances Platinum Resistance in Uterine Serous Carcinoma
by: Zeng, Xiang
Published: (2020)